Can combining ESG with GLP-1 receptor agonists help? How the procedure and medication work together within a physician-led plan.
內容
要點
- Two of the most talked-about tools in modern weight management are endoscopic sleeve gastroplasty (ESG) and GLP-1 receptor agonists (a class of medication such as semaglutide). A natural question follows: can using them together help more than either alone? This article explains how they work and how a combined approach is considered within a physician-led plan.
Two different tools, two mechanisms
Understanding why combining them is even discussed starts with how each works:
- ESG is a procedure. It reshapes the stomach into a narrower sleeve using sutures placed through an endoscope (a thin camera passed via the mouth), so the stomach holds less and empties more slowly. This is a structural change to capacity.
- GLP-1 receptor agonists are medications. GLP-1 (glucagon-like peptide-1) is a natural hormone that helps regulate appetite and blood sugar; these medicines mimic it, which can reduce hunger and help you feel full sooner. This is a change to appetite signalling.
One reduces capacity; the other influences appetite. Because they act on different parts of the picture, there is a logical rationale for using them in combination.
Why a combined approach is considered
For some people, a single tool does not fully address their situation. A structural change (ESG) tackles portion capacity, while medication (GLP-1) can support appetite control and, in some cases, help maintain progress. Used together within a supervised plan, they may complement each other - the procedure making smaller portions comfortable, the medication helping manage hunger between meals.
It is important to keep this grounded: the approved expectation for ESG combined with lifestyle changes is that patients generally lose about 15-20% of body weight within a year, and results vary by individual. Combining tools is about supporting that journey and individual needs - not a promise of a bigger number. Any combined plan is decided case by case.
How timing can work
There is no one-size-fits-all sequence. Depending on the person, a medical team might consider medication before a procedure, alongside the ESG journey, or as part of longer-term maintenance. The right timing depends on your health, your response, and your goals - which is exactly why this belongs in a physician-led setting rather than being self-directed.
Safety and supervision come first
Combining a procedure with medication is not something to arrange informally. It calls for:
- Medical assessment of your full health picture, including any other conditions and medications.
- Ongoing supervision, because GLP-1 medications can have side effects (such as nausea or digestive upset for some people) that need monitoring.
- Individualised decisions, since what suits one person may not suit another.
At YOUNIFY Clinic, both procedures and medications sit within a physician-led weight and metabolic health program, so any combination is guided, monitored, and adjusted by the medical team.
Habits still do the heavy lifting
Even with two tools working together, the fundamentals remain. ESG and GLP-1 medications are supports, not substitutes for lifestyle change. Balanced eating, appropriate portions, movement, and follow-up are what protect results over time. Weight can return without lasting habit change, whatever combination of tools is used.
Discuss a plan built around you
Whether one tool or a combination fits you is a personal, clinical question best answered together.
To find out whether ESG suits your goals, our medical team can arrange an initial assessment. Contact us on LINE (@younifyclinic) or WhatsApp +66 81 556 9696.
常見問題
Can I take GLP-1 medication after ESG?
For some people, medication is part of the plan alongside or after ESG. Whether it suits you is a clinical decision made by our medical team based on your individual situation.
Does combining them mean I will lose more weight?
Combining tools is about supporting your individual journey, not guaranteeing a larger result. The approved expectation for ESG with lifestyle change is about 15-20% of body weight within a year; results vary by individual.
Are GLP-1 medications safe to use this way?
These medications can have side effects for some people and must be used under medical supervision. A combined plan is monitored and adjusted by the medical team.
醫療記錄
本文僅供一般參考,不能取代醫學檢查、診斷或治療。如果症狀嚴重、變化很快或屬於緊急情況,請及時就醫。
結果因人而異,接受治療前請諮詢醫師。
